Drosik K. Commentary [Phase III clinical trial evaluating the use pazopanib in the treatment of kidney cancer - a discussion assumptions and results of the study]. OncoReview [Internet]. 2012Mar.30 [cited 2024Dec.4];2(1(5):69-0. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/299